Nanosyrinx
Develops targeted intracellular delivery of protein therapeutics for biotech and pharmaceutical drug developers
Highlights
- New on EvolcAdded 2026-11-07
About Nanosyrinx
NanoSyrinx is a synthetic biology company developing a Nanosyringe platform to deliver therapeutic proteins and peptides into the cytosol of targeted cells. Its discovery-stage technology is based on engineered bacterial nanomachines.
The platform is intended to help biopharmaceutical developers deliver biologic medicines to intracellular targets. The company is backed by venture investors and pharmaceutical companies, including Eli Lilly.
The company was founded in 2020 and is based at the University of Warwick site. Its team works across synthetic biology, biomanufacturing and early clinical development.
Product: A synthetic biology platform for targeted intracellular delivery of therapeutic proteins and peptides.
Jobs at Nanosyrinx
Leadership
- Joseph Healey · FounderSource: company website
- Nicholas Waterfield · Scientific Advisor and Co-founderSource: company website
- Tom Farrell · CEOSource: company website
More biotech & pharma companies
Nanovery
DNA nanorobot assays for biotech and life sciences researchers quantifying RNA therapeutics and nucleic acid biomarkersNew on EvolcNeobe Therapeutics
Engineers live bacterial therapeutics to help immunotherapies reach solid tumours in patients with immune-excluded cancersNew on EvolcNeoceuticals
Paediatric and specialist oral medicines and nutritional products for healthcare markets in the UK and overseasNew on EvolcNeon Healthcare
Supplies prescription medicines to hospitals, pharmacies and other healthcare providersNew on EvolcNeovac
Develops lipid platforms and formulation kits for researchers advancing RNA therapeuticsNew on EvolcNeurolieve Biosciences
Developing a non-opioid biologic for patients with neuropathic pain, designed to relieve pain and support nerve regenerationYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.